El País in English5h
40 million lives later: The dangers of erasing AIDS from the works of art it inspired
The Smithsonian’s decision to change the name of a work by Félix González-Torres – cancelling out the express tribute to his ...
This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
HIV stigma tied to moral judgments, complicating destigmatization efforts
Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...
US aid freeze sows disruption in HIV, malaria product supply chains
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases including HIV and malaria in some of the world's poorest countries, and ...
US aid freeze puts HIV-positive orphans in Kenya at risk as medical supplies dwindle
Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and ...
Emergency Food, TB Tests and H.I.V. Drugs: Vital Health Aid Remains Frozen Despite Court Ruling
On Thursday night Judge Amir H. Ali of the U.S. District Court for the District of Columbia denied a motion to hold the Trump ...
Lancashire Telegraph1d
Tackle HIV Challenging Stigma Garden set for RHS Chelsea Flower Show
This May will see the Tackle HIV Challenging Stigma Garden in full bloom at the RHS Chelsea Flower Show, with visitors set to view how Thomas and Malde have used the magic of horticulture to tell the ...
unaids1d
UNAIDS launches the development of the new Global AIDS Strategy 2026-2031
This is why UNAIDS is launching the development of the new Global AIDS Strategy 2026-2031, an ambitious, inclusive, and action-driven plan that will guide the global HIV response for the next five ...
Trump's foreign aid freeze halted a crucial program fighting HIV in Africa. Here's what's at stake
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...
PharmiWeb2d
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...